Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
XJO | XJO - Bear Posts only (Factors which might cause the markets to fall) | 13:02 | 15K | 2.5M | |||
|
|||||||
XJO | 22/04 Indices | 11:46 | 34 | 4.6K | |||
|
|||||||
XJO | Hang Seng - HSI | 26/04/24 | 125 | 14K | |||
|
See All Discussions